Form 4: Caris Life Sciences Executive Sells Shares
Insider Transaction (Form 4)
Brian J Brille, See Remarks and a Director of Caris Life Sciences, Inc., sold 400,000 shares of common stock on September 17, 2026 for $30.33 per share.
Summary
- Option exercise/conversion: acquired 400,000 Common Stock at $2.44 ($976,000) on September 17, 2026; holds 630,303 after (Direct).
- Open-market sale: disposed of 400,000 Common Stock at $30.33 ($12,132,080) on September 17, 2026; holds 230,303 after (Direct).
- Option exercise/conversion: disposed of 400,000 Stock Option on September 17, 2026; holds 1,600,000 after (Direct).
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $12,132,080 of stock on the open market.
Insider Transactions
Brian J Brille — Director, Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-17 | Option exercise/conversion | Common Stock | 400,000 | $2 | $976.0K | 630,303 |
| 2026-09-17 | Open-market sale | Common Stock | 400,000 | $30 | $12.1M | 230,303 |
| 2026-09-17 | Option exercise/conversion | Stock Option | 400,000 | — | — | 1,600,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-17 | Option exercise/conversion (400,000 shares) |
| 2026-09-17 | Open-market sale (400,000 shares) |
| 2026-09-17 | Option exercise/conversion (400,000 shares) |
Keywords
insider transaction, Form 4, CAI, Caris Life Sciences, Inc., bearish, Brian J Brille
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.